Citi Upgrades Gilead Sciences (GILD) to Buy, Raises Target to $49
Go back to Citi Upgrades Gilead Sciences (GILD) to Buy, Raises Target to $49| Gilead Sciences (NASDAQ: GILD) | Delayed: 133.21 +2.35 (1.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.86 | 52 Week High | $108.63 | |||
| Open | $132.10 | 52 Week Low | $71.39 | |||
| Day High | $134.09 | P/E | 73.60 | |||
| Day Low | $130.59 | EPS | $1.81 | |||
| Volume | 8,201,933 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
